MINING.COM

Buffalo Potash Announces Initiation of Maiden Resource Estimate and Preliminary Economic Assessment for Flagship Disley Project

Buffalo Potash has engaged Micon International to prepare a Mineral Resource Estimate and Preliminary Economic Assessment, anticipated to be completed Q2 2026 Micon International has extensive ...

FibroBiologics Reports Full Year 2025 Financial Results and Provides Corporate Update

Planning for phase 1/2 clinical trial initiation in Australia utilizing CYWC628 to treat diabetic foot ulcers in the first half of 2026Improved ...

AbCellera Biologics Inc. (ABCL) Q4 2025 Earnings Call Transcript

Q4 2025 Earnings Call February 24, 2026 5:00 PM ESTCompany ParticipantsTryn Stimart - Chief Legal Officer, CCO, ...

Vaxcyte, Inc. (PCVX) Q4 2025 Earnings Call Transcript

Q4 2025 Earnings Call February 24, 2026 4:30 PM ESTCompany ParticipantsAndrew Guggenhime - President & CFOGrant Pickering ...

Atea Pharmaceuticals Presents Preclinical Results Supporting First-in-Class Potential of AT-587 for Treatment of Hepatitis E Virus at CROI 2026

Results Demonstrate AT-587 To Be Highly Potent In Vitro Against Hepatitis E Virus Initiation of Phase 1 Clinical Program Anticipated ...
Rutgers University

When Influencers Raise a Glass, Young Viewers Want to Join Them

Alcohol cues tucked into lifestyle posts increased young adults’ self-reported desire to drink, a Rutgers Health-led study ...

Aspire Biopharma Announces the Appointment of New Member to Its Board of Directors

New independent director Phillip Balatsos brings commercial and capital markets expertise to drive development ...

North Shore Continues To Advance Rio Puerco Towards Drilling

North Shore Uranium Ltd. (TSX-V:NSU) ("North Shore" or the "Company") is pleased to announce that it has filed a Minimal ...

Aspire Biopharma’s Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, to Showcase BUZZ BOMB(TM) Caffeine and its Innovative Sublingual Delivery Technology at The Sports ...

ESTERO, FL / ACCESS Newswire / February 5, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the ...

Moderna Receives Refusal-to-File Letter from the U.S. Food and Drug Administration for Its Investigational Seasonal Influenza Vaccine, mRNA-1010

Refusal to review the submission is inconsistent with feedback at pre-Phase 3 and pre-submission consultations; Moderna ...

Aspire Biopharma’s Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, Partners with Blue Shark Beverages to Expand Southern California Distribution

ESTERO, FL / ACCESS Newswire / February 3, 2026 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the ...
The Purdue Exponent

Research suggests influencers tempt young people to drink

Casual cues - such as a wine bottle on a table during a podcast - really do matter, according to the findings.